nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobutrol—Infection—Carboplatin—testicular cancer	0.0179	0.0179	CcSEcCtD
Gadobutrol—Pain—Carboplatin—testicular cancer	0.0154	0.0154	CcSEcCtD
Gadobutrol—Body temperature increased—Carboplatin—testicular cancer	0.0142	0.0142	CcSEcCtD
Gadobutrol—Urine abnormality—Epirubicin—testicular cancer	0.0137	0.0137	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Epirubicin—testicular cancer	0.0129	0.0129	CcSEcCtD
Gadobutrol—Urine abnormality—Doxorubicin—testicular cancer	0.0127	0.0127	CcSEcCtD
Gadobutrol—Aphasia—Methotrexate—testicular cancer	0.0125	0.0125	CcSEcCtD
Gadobutrol—Urine analysis abnormal—Doxorubicin—testicular cancer	0.012	0.012	CcSEcCtD
Gadobutrol—Hypoaesthesia—Vinblastine—testicular cancer	0.0119	0.0119	CcSEcCtD
Gadobutrol—Parosmia—Epirubicin—testicular cancer	0.0117	0.0117	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Cisplatin—testicular cancer	0.0111	0.0111	CcSEcCtD
Gadobutrol—Parosmia—Doxorubicin—testicular cancer	0.0108	0.0108	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Etoposide—testicular cancer	0.0102	0.0102	CcSEcCtD
Gadobutrol—Hypoaesthesia—Bleomycin—testicular cancer	0.01	0.01	CcSEcCtD
Gadobutrol—Pollakiuria—Ifosfamide—testicular cancer	0.00995	0.00995	CcSEcCtD
Gadobutrol—Convulsion—Chlorambucil—testicular cancer	0.00984	0.00984	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Cisplatin—testicular cancer	0.00982	0.00982	CcSEcCtD
Gadobutrol—Vertigo—Vinblastine—testicular cancer	0.00935	0.00935	CcSEcCtD
Gadobutrol—Injection site pain—Epirubicin—testicular cancer	0.00931	0.00931	CcSEcCtD
Gadobutrol—Infection—Chlorambucil—testicular cancer	0.0092	0.0092	CcSEcCtD
Gadobutrol—Sweating increased—Cisplatin—testicular cancer	0.00905	0.00905	CcSEcCtD
Gadobutrol—Convulsion—Vinblastine—testicular cancer	0.00901	0.00901	CcSEcCtD
Gadobutrol—Injection site pain—Doxorubicin—testicular cancer	0.00862	0.00862	CcSEcCtD
Gadobutrol—Visual impairment—Ifosfamide—testicular cancer	0.00831	0.00831	CcSEcCtD
Gadobutrol—Sweating increased—Etoposide—testicular cancer	0.00829	0.00829	CcSEcCtD
Gadobutrol—Pain—Chlorambucil—testicular cancer	0.00792	0.00792	CcSEcCtD
Gadobutrol—Paraesthesia—Vinblastine—testicular cancer	0.00762	0.00762	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00758	0.00758	CcSEcCtD
Gadobutrol—Abdominal pain—Chlorambucil—testicular cancer	0.00732	0.00732	CcSEcCtD
Gadobutrol—Body temperature increased—Chlorambucil—testicular cancer	0.00732	0.00732	CcSEcCtD
Gadobutrol—Pain—Vinblastine—testicular cancer	0.00726	0.00726	CcSEcCtD
Gadobutrol—Anaphylactic shock—Bleomycin—testicular cancer	0.00717	0.00717	CcSEcCtD
Gadobutrol—Visual impairment—Cisplatin—testicular cancer	0.00717	0.00717	CcSEcCtD
Gadobutrol—Infection—Bleomycin—testicular cancer	0.00712	0.00712	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Vinblastine—testicular cancer	0.00694	0.00694	CcSEcCtD
Gadobutrol—Hypersensitivity—Chlorambucil—testicular cancer	0.00683	0.00683	CcSEcCtD
Gadobutrol—Hypoaesthesia—Etoposide—testicular cancer	0.00678	0.00678	CcSEcCtD
Gadobutrol—Vertigo—Ifosfamide—testicular cancer	0.00675	0.00675	CcSEcCtD
Gadobutrol—Abdominal pain—Vinblastine—testicular cancer	0.00671	0.00671	CcSEcCtD
Gadobutrol—Infection—Dactinomycin—testicular cancer	0.00664	0.00664	CcSEcCtD
Gadobutrol—Palpitations—Ifosfamide—testicular cancer	0.00664	0.00664	CcSEcCtD
Gadobutrol—Abnormal vision—Epirubicin—testicular cancer	0.00663	0.00663	CcSEcCtD
Gadobutrol—Convulsion—Ifosfamide—testicular cancer	0.00651	0.00651	CcSEcCtD
Gadobutrol—Paraesthesia—Bleomycin—testicular cancer	0.00644	0.00644	CcSEcCtD
Gadobutrol—Dyspnoea—Bleomycin—testicular cancer	0.00639	0.00639	CcSEcCtD
Gadobutrol—Diarrhoea—Chlorambucil—testicular cancer	0.00634	0.00634	CcSEcCtD
Gadobutrol—Hypersensitivity—Vinblastine—testicular cancer	0.00625	0.00625	CcSEcCtD
Gadobutrol—Abnormal vision—Doxorubicin—testicular cancer	0.00614	0.00614	CcSEcCtD
Gadobutrol—Pain—Bleomycin—testicular cancer	0.00613	0.00613	CcSEcCtD
Gadobutrol—Anaphylactic shock—Ifosfamide—testicular cancer	0.00613	0.00613	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00609	0.00609	CcSEcCtD
Gadobutrol—Infection—Ifosfamide—testicular cancer	0.00609	0.00609	CcSEcCtD
Gadobutrol—Hyperhidrosis—Ifosfamide—testicular cancer	0.00592	0.00592	CcSEcCtD
Gadobutrol—Hot flush—Epirubicin—testicular cancer	0.0059	0.0059	CcSEcCtD
Gadobutrol—Vomiting—Chlorambucil—testicular cancer	0.00589	0.00589	CcSEcCtD
Gadobutrol—Menopausal symptoms—Epirubicin—testicular cancer	0.00585	0.00585	CcSEcCtD
Gadobutrol—Diarrhoea—Vinblastine—testicular cancer	0.00581	0.00581	CcSEcCtD
Gadobutrol—Dysgeusia—Etoposide—testicular cancer	0.00581	0.00581	CcSEcCtD
Gadobutrol—Pain—Dactinomycin—testicular cancer	0.00572	0.00572	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Epirubicin—testicular cancer	0.0057	0.0057	CcSEcCtD
Gadobutrol—Body temperature increased—Bleomycin—testicular cancer	0.00567	0.00567	CcSEcCtD
Gadobutrol—Dizziness—Vinblastine—testicular cancer	0.00561	0.00561	CcSEcCtD
Gadobutrol—Convulsion—Cisplatin—testicular cancer	0.00561	0.00561	CcSEcCtD
Gadobutrol—Nausea—Chlorambucil—testicular cancer	0.0055	0.0055	CcSEcCtD
Gadobutrol—Paraesthesia—Ifosfamide—testicular cancer	0.0055	0.0055	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00547	0.00547	CcSEcCtD
Gadobutrol—Dyspnoea—Ifosfamide—testicular cancer	0.00546	0.00546	CcSEcCtD
Gadobutrol—Hot flush—Doxorubicin—testicular cancer	0.00546	0.00546	CcSEcCtD
Gadobutrol—Menopausal symptoms—Doxorubicin—testicular cancer	0.00541	0.00541	CcSEcCtD
Gadobutrol—Vomiting—Vinblastine—testicular cancer	0.0054	0.0054	CcSEcCtD
Gadobutrol—Vertigo—Etoposide—testicular cancer	0.00533	0.00533	CcSEcCtD
Gadobutrol—Headache—Vinblastine—testicular cancer	0.00532	0.00532	CcSEcCtD
Gadobutrol—Body temperature increased—Dactinomycin—testicular cancer	0.00529	0.00529	CcSEcCtD
Gadobutrol—Abdominal pain—Dactinomycin—testicular cancer	0.00529	0.00529	CcSEcCtD
Gadobutrol—Anaphylactic shock—Cisplatin—testicular cancer	0.00528	0.00528	CcSEcCtD
Gadobutrol—Hypersensitivity—Bleomycin—testicular cancer	0.00528	0.00528	CcSEcCtD
Gadobutrol—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.00528	0.00528	CcSEcCtD
Gadobutrol—Infection—Cisplatin—testicular cancer	0.00525	0.00525	CcSEcCtD
Gadobutrol—Pain—Ifosfamide—testicular cancer	0.00524	0.00524	CcSEcCtD
Gadobutrol—Convulsion—Etoposide—testicular cancer	0.00514	0.00514	CcSEcCtD
Gadobutrol—Hyperhidrosis—Cisplatin—testicular cancer	0.00511	0.00511	CcSEcCtD
Gadobutrol—Nausea—Vinblastine—testicular cancer	0.00504	0.00504	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Epirubicin—testicular cancer	0.00504	0.00504	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00501	0.00501	CcSEcCtD
Gadobutrol—Hypersensitivity—Dactinomycin—testicular cancer	0.00493	0.00493	CcSEcCtD
Gadobutrol—Body temperature increased—Ifosfamide—testicular cancer	0.00484	0.00484	CcSEcCtD
Gadobutrol—Abdominal pain—Ifosfamide—testicular cancer	0.00484	0.00484	CcSEcCtD
Gadobutrol—Anaphylactic shock—Etoposide—testicular cancer	0.00484	0.00484	CcSEcCtD
Gadobutrol—Infection—Etoposide—testicular cancer	0.00481	0.00481	CcSEcCtD
Gadobutrol—Paraesthesia—Cisplatin—testicular cancer	0.00474	0.00474	CcSEcCtD
Gadobutrol—Dyspnoea—Cisplatin—testicular cancer	0.00471	0.00471	CcSEcCtD
Gadobutrol—Hyperhidrosis—Etoposide—testicular cancer	0.00468	0.00468	CcSEcCtD
Gadobutrol—Orthostatic hypotension—Doxorubicin—testicular cancer	0.00466	0.00466	CcSEcCtD
Gadobutrol—Diarrhoea—Dactinomycin—testicular cancer	0.00458	0.00458	CcSEcCtD
Gadobutrol—Vomiting—Bleomycin—testicular cancer	0.00456	0.00456	CcSEcCtD
Gadobutrol—Rash—Bleomycin—testicular cancer	0.00452	0.00452	CcSEcCtD
Gadobutrol—Pain—Cisplatin—testicular cancer	0.00452	0.00452	CcSEcCtD
Gadobutrol—Dermatitis—Bleomycin—testicular cancer	0.00452	0.00452	CcSEcCtD
Gadobutrol—Hypersensitivity—Ifosfamide—testicular cancer	0.00451	0.00451	CcSEcCtD
Gadobutrol—Pollakiuria—Epirubicin—testicular cancer	0.00441	0.00441	CcSEcCtD
Gadobutrol—Paraesthesia—Etoposide—testicular cancer	0.00435	0.00435	CcSEcCtD
Gadobutrol—Dyspnoea—Etoposide—testicular cancer	0.00432	0.00432	CcSEcCtD
Gadobutrol—Nausea—Bleomycin—testicular cancer	0.00426	0.00426	CcSEcCtD
Gadobutrol—Vomiting—Dactinomycin—testicular cancer	0.00425	0.00425	CcSEcCtD
Gadobutrol—Rash—Dactinomycin—testicular cancer	0.00422	0.00422	CcSEcCtD
Gadobutrol—Diarrhoea—Ifosfamide—testicular cancer	0.00419	0.00419	CcSEcCtD
Gadobutrol—Body temperature increased—Cisplatin—testicular cancer	0.00418	0.00418	CcSEcCtD
Gadobutrol—Pain—Etoposide—testicular cancer	0.00414	0.00414	CcSEcCtD
Gadobutrol—Pollakiuria—Doxorubicin—testicular cancer	0.00408	0.00408	CcSEcCtD
Gadobutrol—Dizziness—Ifosfamide—testicular cancer	0.00405	0.00405	CcSEcCtD
Gadobutrol—Nausea—Dactinomycin—testicular cancer	0.00397	0.00397	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Etoposide—testicular cancer	0.00396	0.00396	CcSEcCtD
Gadobutrol—Visual impairment—Methotrexate—testicular cancer	0.00393	0.00393	CcSEcCtD
Gadobutrol—Vomiting—Ifosfamide—testicular cancer	0.0039	0.0039	CcSEcCtD
Gadobutrol—Hypersensitivity—Cisplatin—testicular cancer	0.00389	0.00389	CcSEcCtD
Gadobutrol—Rash—Ifosfamide—testicular cancer	0.00386	0.00386	CcSEcCtD
Gadobutrol—Dermatitis—Ifosfamide—testicular cancer	0.00386	0.00386	CcSEcCtD
Gadobutrol—Abdominal pain—Etoposide—testicular cancer	0.00383	0.00383	CcSEcCtD
Gadobutrol—Body temperature increased—Etoposide—testicular cancer	0.00383	0.00383	CcSEcCtD
Gadobutrol—Hypoaesthesia—Epirubicin—testicular cancer	0.0038	0.0038	CcSEcCtD
Gadobutrol—Visual impairment—Epirubicin—testicular cancer	0.00368	0.00368	CcSEcCtD
Gadobutrol—Nausea—Ifosfamide—testicular cancer	0.00364	0.00364	CcSEcCtD
Gadobutrol—Diarrhoea—Cisplatin—testicular cancer	0.00361	0.00361	CcSEcCtD
Gadobutrol—Hypersensitivity—Etoposide—testicular cancer	0.00357	0.00357	CcSEcCtD
Gadobutrol—Hypoaesthesia—Doxorubicin—testicular cancer	0.00352	0.00352	CcSEcCtD
Gadobutrol—Dysgeusia—Methotrexate—testicular cancer	0.00348	0.00348	CcSEcCtD
Gadobutrol—Visual impairment—Doxorubicin—testicular cancer	0.00341	0.00341	CcSEcCtD
Gadobutrol—Vomiting—Cisplatin—testicular cancer	0.00336	0.00336	CcSEcCtD
Gadobutrol—Rash—Cisplatin—testicular cancer	0.00333	0.00333	CcSEcCtD
Gadobutrol—Dermatitis—Cisplatin—testicular cancer	0.00333	0.00333	CcSEcCtD
Gadobutrol—Diarrhoea—Etoposide—testicular cancer	0.00331	0.00331	CcSEcCtD
Gadobutrol—Dysgeusia—Epirubicin—testicular cancer	0.00326	0.00326	CcSEcCtD
Gadobutrol—Dizziness—Etoposide—testicular cancer	0.0032	0.0032	CcSEcCtD
Gadobutrol—Vertigo—Methotrexate—testicular cancer	0.00319	0.00319	CcSEcCtD
Gadobutrol—Nausea—Cisplatin—testicular cancer	0.00314	0.00314	CcSEcCtD
Gadobutrol—Convulsion—Methotrexate—testicular cancer	0.00308	0.00308	CcSEcCtD
Gadobutrol—Vomiting—Etoposide—testicular cancer	0.00308	0.00308	CcSEcCtD
Gadobutrol—Rash—Etoposide—testicular cancer	0.00305	0.00305	CcSEcCtD
Gadobutrol—Dermatitis—Etoposide—testicular cancer	0.00305	0.00305	CcSEcCtD
Gadobutrol—Headache—Etoposide—testicular cancer	0.00303	0.00303	CcSEcCtD
Gadobutrol—Dysgeusia—Doxorubicin—testicular cancer	0.00301	0.00301	CcSEcCtD
Gadobutrol—Vertigo—Epirubicin—testicular cancer	0.00299	0.00299	CcSEcCtD
Gadobutrol—Palpitations—Epirubicin—testicular cancer	0.00294	0.00294	CcSEcCtD
Gadobutrol—Anaphylactic shock—Methotrexate—testicular cancer	0.0029	0.0029	CcSEcCtD
Gadobutrol—Convulsion—Epirubicin—testicular cancer	0.00288	0.00288	CcSEcCtD
Gadobutrol—Infection—Methotrexate—testicular cancer	0.00288	0.00288	CcSEcCtD
Gadobutrol—Nausea—Etoposide—testicular cancer	0.00287	0.00287	CcSEcCtD
Gadobutrol—Hyperhidrosis—Methotrexate—testicular cancer	0.0028	0.0028	CcSEcCtD
Gadobutrol—Dry mouth—Epirubicin—testicular cancer	0.00277	0.00277	CcSEcCtD
Gadobutrol—Vertigo—Doxorubicin—testicular cancer	0.00276	0.00276	CcSEcCtD
Gadobutrol—Palpitations—Doxorubicin—testicular cancer	0.00272	0.00272	CcSEcCtD
Gadobutrol—Anaphylactic shock—Epirubicin—testicular cancer	0.00271	0.00271	CcSEcCtD
Gadobutrol—Infection—Epirubicin—testicular cancer	0.0027	0.0027	CcSEcCtD
Gadobutrol—Convulsion—Doxorubicin—testicular cancer	0.00267	0.00267	CcSEcCtD
Gadobutrol—Hyperhidrosis—Epirubicin—testicular cancer	0.00262	0.00262	CcSEcCtD
Gadobutrol—Insomnia—Methotrexate—testicular cancer	0.00262	0.00262	CcSEcCtD
Gadobutrol—Paraesthesia—Methotrexate—testicular cancer	0.0026	0.0026	CcSEcCtD
Gadobutrol—Dyspnoea—Methotrexate—testicular cancer	0.00258	0.00258	CcSEcCtD
Gadobutrol—Dry mouth—Doxorubicin—testicular cancer	0.00256	0.00256	CcSEcCtD
Gadobutrol—Anaphylactic shock—Doxorubicin—testicular cancer	0.00251	0.00251	CcSEcCtD
Gadobutrol—Infection—Doxorubicin—testicular cancer	0.00249	0.00249	CcSEcCtD
Gadobutrol—Pain—Methotrexate—testicular cancer	0.00248	0.00248	CcSEcCtD
Gadobutrol—Insomnia—Epirubicin—testicular cancer	0.00245	0.00245	CcSEcCtD
Gadobutrol—Paraesthesia—Epirubicin—testicular cancer	0.00244	0.00244	CcSEcCtD
Gadobutrol—Hyperhidrosis—Doxorubicin—testicular cancer	0.00243	0.00243	CcSEcCtD
Gadobutrol—Dyspnoea—Epirubicin—testicular cancer	0.00242	0.00242	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Methotrexate—testicular cancer	0.00237	0.00237	CcSEcCtD
Gadobutrol—Pain—Epirubicin—testicular cancer	0.00232	0.00232	CcSEcCtD
Gadobutrol—Abdominal pain—Methotrexate—testicular cancer	0.00229	0.00229	CcSEcCtD
Gadobutrol—Body temperature increased—Methotrexate—testicular cancer	0.00229	0.00229	CcSEcCtD
Gadobutrol—Insomnia—Doxorubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Gadobutrol—Paraesthesia—Doxorubicin—testicular cancer	0.00225	0.00225	CcSEcCtD
Gadobutrol—Dyspnoea—Doxorubicin—testicular cancer	0.00224	0.00224	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Epirubicin—testicular cancer	0.00222	0.00222	CcSEcCtD
Gadobutrol—Pain—Doxorubicin—testicular cancer	0.00215	0.00215	CcSEcCtD
Gadobutrol—Body temperature increased—Epirubicin—testicular cancer	0.00214	0.00214	CcSEcCtD
Gadobutrol—Abdominal pain—Epirubicin—testicular cancer	0.00214	0.00214	CcSEcCtD
Gadobutrol—Hypersensitivity—Methotrexate—testicular cancer	0.00214	0.00214	CcSEcCtD
Gadobutrol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00205	0.00205	CcSEcCtD
Gadobutrol—Hypersensitivity—Epirubicin—testicular cancer	0.002	0.002	CcSEcCtD
Gadobutrol—Abdominal pain—Doxorubicin—testicular cancer	0.00198	0.00198	CcSEcCtD
Gadobutrol—Body temperature increased—Doxorubicin—testicular cancer	0.00198	0.00198	CcSEcCtD
Gadobutrol—Diarrhoea—Methotrexate—testicular cancer	0.00198	0.00198	CcSEcCtD
Gadobutrol—Dizziness—Methotrexate—testicular cancer	0.00192	0.00192	CcSEcCtD
Gadobutrol—Diarrhoea—Epirubicin—testicular cancer	0.00186	0.00186	CcSEcCtD
Gadobutrol—Hypersensitivity—Doxorubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Gadobutrol—Vomiting—Methotrexate—testicular cancer	0.00184	0.00184	CcSEcCtD
Gadobutrol—Rash—Methotrexate—testicular cancer	0.00183	0.00183	CcSEcCtD
Gadobutrol—Dermatitis—Methotrexate—testicular cancer	0.00183	0.00183	CcSEcCtD
Gadobutrol—Headache—Methotrexate—testicular cancer	0.00182	0.00182	CcSEcCtD
Gadobutrol—Dizziness—Epirubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Gadobutrol—Vomiting—Epirubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Gadobutrol—Nausea—Methotrexate—testicular cancer	0.00172	0.00172	CcSEcCtD
Gadobutrol—Diarrhoea—Doxorubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Gadobutrol—Rash—Epirubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Gadobutrol—Dermatitis—Epirubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Gadobutrol—Headache—Epirubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Gadobutrol—Dizziness—Doxorubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Gadobutrol—Nausea—Epirubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Gadobutrol—Vomiting—Doxorubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Gadobutrol—Rash—Doxorubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Gadobutrol—Dermatitis—Doxorubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Gadobutrol—Headache—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Gadobutrol—Nausea—Doxorubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
